This site is intended for healthcare professionals

Go to /sign-in page

You can view 5 more pages before signing in

Presentation of pituitary tumours

Last reviewed dd mmm yyyy. Last edited dd mmm yyyy

Authoring team

Pituitary tumours may present because of either their mass their or endocrine effects.

Mass effects are usually due to large tumours and include:

  • headache - non-specific
  • visual field defects - from pressure on the inferior of the optic chiasm; begins as a superior temporal quadrantanopia progressing to bitemporal hemianopia
  • cavernous sinus compression - resulting from lateral extension of the tumour into the cavernous sinus. Most often produces a III nerve palsy; may also compress the IV and VI nerves, and produce sensory loss in the first and second divisions of cranial V.
  • rarely, erosion of the mass through the sphenoid sinus produces a CSF rhinorrhoea

Endocrine effects may be due to oversecretion of specific hormones, usually one, especially caused by small tumours:

  • hyperprolactinaemia - most common
  • gigantism / acromegaly - from GH hypersecretion
  • Cushing's disease - from ACTH hypersecretion - presents as Cushing's syndrome
  • rarely, hypersecretion of TSH, FSH, LH

Or due to undersecretion of specific hormones, presenting as panhypopituitarism. This may be associated with compression of the pituitary gland from a large tumour, or may result from small tumours.

Pituitary adenomas may also present as pituitary apoplexy.


Create an account to add page annotations

Add information to this page that would be handy to have on hand during a consultation, such as a web address or phone number. This information will always be displayed when you visit this page

The content herein is provided for informational purposes and does not replace the need to apply professional clinical judgement when diagnosing or treating any medical condition. A licensed medical practitioner should be consulted for diagnosis and treatment of any and all medical conditions.

Connect

Copyright 2024 Oxbridge Solutions Limited, a subsidiary of OmniaMed Communications Limited. All rights reserved. Any distribution or duplication of the information contained herein is strictly prohibited. Oxbridge Solutions receives funding from advertising but maintains editorial independence.